Antiprothrombin antibodies have been proposed as potential new biomarkers for thrombosis
and/or pregnancy morbidity in the setting of the antiphospholipid syndrome (APS) …

Antiprotrombin antibodies belong to the family of antiphospholipid antibodies (aPLs). The
clinical relevance of antiprothrombin antibodies has not been established and it depends on …

Antiprothrombin antibodies, measured with phosphatidylserine/prothrombin complex
(aPS/PT) ELISA, have been reported to be associated with antiphospholipid syndrome …

The antiphospholipid antibodies present in antiphospholipid syndrome (APS) are directed at
a number of phospholipid-binding proteins: β2 glycoprotein I (β2GPI), prothrombin, and so …

According to the preliminary classification criteria of the antiphospholipid syndrome
(APS)(Sapporo Criteria), β2-glycoprotein I (β2GPI)-dependent anticardiolipin antibodies …

Anti‐phospholipid antibodies (aPL) are associated with an increased risk of thrombosis and
recurrent fetal loss. Antibodies to prothrombin (aPT) have been associated with the anti …

Antibodies to prothrombin are detected by directly coating prothrombin on irradiated ELISA
plates (aPT) or by using the phosphatidylserine/prothrombin complex as antigen (aPS/PT) …

Antiphospholipid antibodies (aPL) represent a group of autoantibodies directed against
phospholipids. These antibodies may arise in a number of autoimmune conditions, of which …

Antiphospholipid antibodies (aPL) represent a heterogeneous group of antibodies that
recognize various antigenic targets including beta2 glycoprotein I (β2GPI), prothrombin (PT) …

Among the diagnostic assays for anti-phospholipid syndrome (APS), lupus anticoagulant
(LA) is the strongest predictor of thrombosis; however, it presents several limitations as …